Modulation of GLP-1 Levels by a Genetic Variant That Regulates the Cardiovascular Effects of Intensive Glycemic Control in ACCORD

OBJECTIVE: A genome-wide association study in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial identified two markers (rs57922 and rs9299870) that were significantly associated with cardiovascular mortality during intensive glycemic control and could potentially be used, when com...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Hetal S., Morieri, Mario Luca, Marcovina, Santica M., Sigal, Ronald J., Gerstein, Hertzel C., Wagner, Michael J., Motsinger-Reif, Alison A., Buse, John B., Kraft, Peter, Mychaleckyj, Josyf C., Doria, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2018
Materias:
Cardiovascular and Metabolic Risk
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780047/
https://www.ncbi.nlm.nih.gov/pubmed/29183908
http://dx.doi.org/10.2337/dc17-1638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780047/
https://www.ncbi.nlm.nih.gov/pubmed/29183908
http://dx.doi.org/10.2337/dc17-1638

Ejemplares similares